, which is caused by small mites that make their way into the eyelid. This causes chronic inflammation that can, in severe cases, cause problems on the cornea of the eye itself. The disease can also cause damage to eyelashes and cause other allergic reactions. Despite its prevalence, there wasn’t any good treatment for the disease until, an eyedrop solution that directly targets the mites that cause the disease. The treatment hit the market in late August 2023.
An FDA advisory panel unanimously voted Monday to recommend Eli Lilly’s Alzheimer’s drug donanemab making the drug’s final approval more likely. Data from clinical trials suggest the drug can slow the progression of Alzheimer’s by about 29% compared to a placebo, though it does risk some severe side effects.
contributor and healthcare analyst Joshua Cohen on the decision. “In turn, this would provide AD patients and their caregivers another treatment option in a therapeutic area with a considerable amount of unmet need.”s Under 30 Europe startup Germany-based Cara Care, which developed a self-guided cognitive behavioral therapy-based app treatment for inflammatory bowel disease. While digital therapeutics companies have struggled to get reimbursement in the U.S.
Entertainment Entertainment Latest News, Entertainment Entertainment Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: ForbesTech - 🏆 318. / 59 Read more »